SECOND SIGHT MED PRODS INC - COM (EYES)

CUSIP: 81362J100

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
448,326
Share change
-632,359
Total reported value
$5,744,859
Price per share
$12.81
Number of holders
24
Value change
-$7,019,373
Number of buys
15
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 81362J100?
CUSIP 81362J100 identifies EYES - SECOND SIGHT MED PRODS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM (EYES) as of Q1 2015

As of 31 Mar 2015, SECOND SIGHT MED PRODS INC - COM (EYES) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 448,326 shares. The largest 10 holders included ORACLE INVESTMENT MANAGEMENT INC, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, Carl Domino Inc, GEODE CAPITAL MANAGEMENT, LLC, Squarepoint Ops LLC, STATE STREET CORP, MORGAN STANLEY, Bank of New York Mellon Corp, and ATHENA CAPITAL ADVISORS LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.